Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Tofacitinib treatment is used for teenagers with alopecia areata.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Ritlecitinib is an effective new treatment for Alopecia Areata.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Afatinib often causes skin problems that need proactive management.